Brain training game tested for anxiety, depression, and PTSD
NCT ID NCT06273527
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a computer program called COGENT, designed to improve thinking skills like memory and attention in people with anxiety, depression, or PTSD. 128 adults will be randomly assigned to either the COGENT training or a sham program. Researchers will compare changes in cognitive performance and brain activity before and after the training.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- computer-based cognitive training program (COGENT)
- What this could lead to
- If it works, this could point toward a non-drug way to improve thinking and reduce repetitive negative thoughts in people with anxiety, depression, or PTSD.
- What could go wrong
- This is an early-stage study with only 128 participants, and the sham group may also show some improvement. The training is computer-based, so real-world benefits may be limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY DISORDERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UC San Diego
RECRUITINGSan Diego, California, 92037, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your voice may hold clues to depression – a new device listens in
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Could the sound of your voice reveal depression?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Middle school jitters: a new program aims to smooth the transition for anxious students
- Could a new drug offer hope for Treatment-Resistant depression?